Heart failure: Highlights from new consensus guidelines

Cleveland Clinic Journal of Medicine

Volumn 67, Issue 1, 2000, Pages 13-16

  Young, James ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; LISINOPRIL; SPIRONOLACTONE;

ADRENERGIC SYSTEM; DIET; ECHOCARDIOGRAPHY; EXERCISE; FLUID RETENTION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MORTALITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOKING;

EID: 0033984431     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.1.13     Document Type: Review

References (11)

1. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273:1450-1456.
2. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel J-P. Clinical effects of β-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998; 98:1184-1191.
3. Roberts WC, Packer M, Cohn JN, et al. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999; 83(suppl 2A):1A-38A.
4. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20:248-254.
5. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation 1996; 94:2285-2296.
6. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-717.
7. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation 1989; 79:324-329.
8. Coates AJS, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85:2119-2131.
9. Temporelli PL, Giannuzzi P, Corra U, Balestroni G, Tavazzi L, for the ELVD-CHF Study Group. Long-term exercise training in patients with chronic heart failure: results of the ELVD-CHF (exercise in left ventricular dysfunction and chronic heart failure) trial [abstract]. Eur Heart J 1998; 19(suppl):3.
10. Sindone A, Baker V, Sammel N, Keogh A, MacDonald P. Long-term follow-up of patients randomised to exercise training and cardiac rehabilitation in moderate heart failure [abstract]. Eur Heart J 1998; 19(suppl):3.
11. Belardinelli R, Balestra S, Cesaretti L, Cinaci G, Purcaro A. Long-term moderate exercise training in chronic heart failure: effect on mortality and morbidity [abstract]. Eur Heart J 1998; 19(suppl):3.